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The establishment of an efﬁcient and reliable protein-puriﬁcation pipeline is
essential for the success of structural genomic projects. The SSGCID Protein
Puriﬁcation Group at the University of Washington (UW-PPG) has established
a robust protein-puriﬁcation pipeline designed to purify 400 proteins per year at
a rate of eight puriﬁcations per week. The pipeline was implemented using two
A ¨ KTAexplorer 100s and four A ¨ KTAprimes to perform immobilized metal-
afﬁnity chromatography (IMAC) and size-exclusion chromatography. Puriﬁca-
tions were completed in a period of 5 d and yielded an average of 53 mg highly
puriﬁed protein. This paper provides a detailed description of the methods used
to purify, characterize and store SSGCID proteins. Some of the puriﬁed proteins
were treated with 3C protease, which was expressed and puriﬁed by UW-PPG
using a similar protocol, to cleave non-native six-histidine tags. The cleavage
was successful in 94% of 214 attempts. Cleaved proteins yielded 2.9% more
structures than uncleaved six-histidine-tagged proteins. This 2.9% improvement
may seem small, but over the course of the project the structure output from
UW-PPG is thus predicted to increase from 260 structures to 318 structures.
Therefore, the outlined protocol with 3C cleavage and subtractive IMAC has
been shown to be a highly efﬁcient method for the standardized puriﬁcation of
recombinant proteins for structure determination via X-ray crystallography.
1. Introduction
The Seattle Structural Genomics Center for Infectious Disease
(SSGCID) was established as a collaboration between Seattle
BioMed, Emerald BioSystems and the University of Washington in
2007. Its aim is to solve three-dimensional structures of pathogenic
proteins from various organisms listed as category A–C agents
according to the National Institute of Allergy and Infectious Diseases
(NIAID) at a rate of 75–100 per year. Owing to the intensity of this
goal, the implementation of a robust protein-puriﬁcation pipeline was
an essential requirement for the success of the SSGCID project. The
primary objective was to develop a standard operating procedure
(SOP) that would support the puriﬁcation of 400 crystal-quality
proteins per year at a rate of eight puriﬁcations per week (Fig. 1). To
accomplish this task, the Protein Puriﬁcation Group at the University
of Washington (UW-PPG) employed two full-time research scientists,
two A ¨TKAexplorer 100s and four A ¨TKAprimes (GE Healthcare,
Piscataway, New Jersey, USA). One of thekey criteria in the design of
the UW-PPG protein-puriﬁcation strategy was that the weekly goals
had to be completed in a period of ﬁve working days in order to ﬁt
within the laboratory schedule. Following this approach, the UW-
PPG implemented a semi-automated protein-puriﬁcation pipeline
based on the capture of bacterial and eukaryotic proteins with
N-terminal histidine tags using metal-afﬁnity chromatography
followed by the cleavage of the N-terminal 6-His tags with 6-His-
MBP-3C protease, which is expressed and puriﬁed in-house, and size-
exclusion chromatography (SEC). This paper presents a detaileddescription of the UW-PPG protein-puriﬁcation SOP and, most
importantly, discusses success rates to demonstrate the efﬁciency of
the outlined protocol.
2. Materials and methods
2.1. Cloning and expression testing
Open reading frames encoding the selected protein targets were
PCR-ampliﬁed in a 96-well format using either genomic DNA or
cDNA as a template. The PCR primers were designed with an
additional ligation-independent cloning (LIC) sequence at their 50
ends that was complementary to the LIC sequence in the plasmid
vector (Choi et al., 2011). Puriﬁed PCR products were then cloned via
LIC (Aslanidis & de Jong, 1990) into the AVA0421 expression vector
(received as a gift from Dr Elizabeth Grayhack; Quartley et al., 2009),
which was derived from pET14b and provides cleavable six-histidine
tags (His tags) at the N-termini of the expressed proteins (the 3C
protease recognition sequence is Leu-Glu-Ala-Gln-Thr-Gln*-Gly-
Pro, where * is the cleavage site; Alexandrov et al., 2004; Choi et al.,
2011). The recombinant plasmids were transformed into Escherichia
coli Rosetta Oxford strain [BL21*(DE3)-R3-pRARE2] cells for
expression testing (Choi et al., 2011) and the proteins which showed
solubility continued to large-scale expression.
Inoculum cultures of lysogeny broth (LB) with appropriate anti-
biotics were grown for approximately 16 h at 310 K as described
by Choi et al. (2011). ZYP-5052 auto-induction medium was freshly
prepared as per Studier’s published protocol (Studier, 2005).
Antibiotics (50 mgm l
 1 ampicillin, 50 mgm l
 1 carbenicillin and/or
34 mgm l
 1 chloramphenicol, depending on strain/plasmid concen-
tration) were added to Pyrex bottles containing 2 l sterile auto-
induction medium as well as 400 ml antifoam (Sigma, St Louis, USA;
Choi et al., 2011). The bottles were inoculated with 3 ml overnight
culture and placed into a LEX bioreactor (Harbinger Biotech,
Ontario, Canada). The cultures were grown for approximately 24 h at
298 K; the temperature was then dropped to 288 K for approximately
72 h. To harvest, the culture was centrifuged at 4000g for 20 min at
277 K. The cell paste was ﬂash-frozen in liquid nitrogen and stored
at 193 K. Large-scale expressions were qualitatively analyzed by
performing a high-throughput screen to determine the level of
expression and solubility prior to puriﬁcation (Choi et al., 2011).
2.2. Protein purification
Frozen bacterial cell pellets (averaging 25 g) were resuspended
in lysis buffer (25 mM HEPES, 500 mM NaCl, 5% glycerol, 30 mM
imidazole, 0.025% sodium azide, 0.5% CHAPS, 10 mM MgCl2,1m M
TCEP, 250 mgm l
 1 AEBSF, 0.05 mgm l
 1 lysozyme pH 7.0). Cells
underwent sonication on ice using a Virtis Versonic 600 sonicator (SP
Scientiﬁc, Gardiner, New York, USA) programmed to run for 30 min
in 15 s intervals at 100 W separated by 15 s resting time. The cell
debris was incubated with 20 ml Benzonase nuclease (25 units ml
 1;
EMD Chemicals, San Diego, California, USA) at room temperature
for 45 min and a ‘total’ sample was taken for subsequent analysis by
SDS–PAGE. Clariﬁcation was achieved by centrifugation at 29 774g
for 75 min at 277 K and a ‘soluble’ sample was collected. Immobilized
metal-afﬁnity chromatography (IMAC) removed the majority of the
native E. coli proteins using HisTrap FF 5 ml columns (GE Health-
care, Piscataway, New Jersey, USA) equilibrated with wash buffer
(25 mM HEPES, 500 mM NaCl, 5% glycerol, 30 mM imidazole,
0.025% sodium azide, 1 mM TCEP pH 7.0). The soluble lysate was
loaded using an A ¨ KTAexplorer 100 (GE Healthcare, Piscataway,
New York, USA). The ﬂowthrough was collected and a sample was
saved. 20 column volumes of wash buffer were run over the column to
remove any unbound protein. The His-tagged protein and any other
Ni-binding proteins (Bolanos-Garcia & Davies, 2006) were eluted
with seven column volumes of elution buffer (25 mM HEPES,
500 mM NaCl, 5% glycerol, 1 mM TCEP, 250 mM imidazole and
0.025% azide pH 7.0) and collected in 3 ml fractions. The OD280
absorbance chromatogram was used to determine which fractions to
pool.
Cleavage of the His tag from the target protein was achieved by
‘in-solution’ digestion in the presence of 3C protease. However, it is
important to note that single-step ‘on-column’ cleavage and separa-
tion of the tagless protein from 3C protease has also been reported to
be successful (Hedhammar et al., 2006). The advantages of the
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Figure 1
Flowchart of the UW-PPG protein-puriﬁcation protocol. Eight SSGCID targets
were puriﬁed per week utilizing two research scientists, two A ¨TKAexplorer 100s
and four A ¨TKAprimes (GE Healthcare, Piscataway, New Jersey, USA). Following
initial immobilized metal-afﬁnity chromatography (IMAC) of the soluble lysates,
the polyhistidine tag was removed from the recombinant protein using 3C protease.
The cleaved protein was separated from the 3C protease, the His-tag peptide,
uncleaved protein and any Ni-binding contaminants through subtractive IMAC.
Size-exclusion chromatography (SEC) was then used as a ﬁnal puriﬁcation step and
SDS–PAGE was used to determine the fractions to pool. The pooled protein was
concentrated to 20–30 mg ml
 1 and stored at 193 K. In our group, the procedures
were carried out on the days noted in the upper right-hand corner of each box.‘in-solution’ technique are that multiple samples can be run in
parallel; the proteins are freely diffusible so that constraints of the
protease needing to be adjacent to a protein are not operant and the
cleavage can proceed further to completion. Owing to the high-
throughput nature of the SSGCID project, the ability to fully cleave
four proteins simultaneously outweighs the extra time spent
performing a separate subtractive IMAC step, making the ‘in-
solution’ method more practical in this case. 3C protease was added
to the protein at a ratio of 1:50(w:w) and the mixture was dialyzed
overnight (generally 18 h) at 277 K in dialysis buffer (25 mM HEPES,
500 mM NaCl, 5% glycerol, 1 mM TCEP and 0.025% azide pH 7.5).
A second IMAC step was used to remove uncleaved protein, the
His-tag peptide, any Ni-binding E. coli contaminant proteins and
the His-tagged 3C protease from the cleaved protein. The sample
was loaded onto a gravity-ﬂow column (Econo-Pac Chromatography
Columns, Bio-Rad, Hercules, California, USA) packed with pre-
equilibrated Ni Sepharose (2.5 or 5 ml depending on the protein
yield; GE Healthcare, Piscataway, New Jersey) and the ﬂowthrough
was collected. Two column volumes of wash buffer (the same as for
the ﬁrst IMAC) purged the resin of unbound sample and this wash
fraction was also collected. The Ni-bound proteins (ideally, 3C
protease, non-His-tagged protein contaminants and uncleaved
protein) were collected from the column upon the addition of four
column volumes of elution buffer (also the same as for the ﬁrst
IMAC). Qualitative analysis of the digestion reaction was performed
by SDS–PAGE and quantitative analysis was performed by
measuring the concentration of protein in the ﬂowthrough, wash and
eluate samples. After determining where the target protein eluted,
the appropriate fraction(s) were concentrated (Amicon Ultra-15
Centrifugal Filter Units, Millipore, Carrigtwohill, Ireland) to
approximately 10–15 ml in preparation for size-exclusion chromato-
graphy (SEC).
Puriﬁcation was completed by performing SEC as a ﬁnal step. The
cleaved protein was loaded using an A ¨ KTAexplorer or A ¨ KTAprime
(GE Healthcare, Piscataway, New Jersey, USA) onto a HiLoad 26/60
Superdex 75 preparative-grade column (GE Healthcare, Piscataway,
New Jersey, USA) that had previously been equilibrated in SEC
buffer (25 mM HEPES, 500 mM NaCl, 5% glycerol, 2 mM DTT,
0.025% azide pH 7.0) and the eluate was collected in 5 ml fractions.
The apparent molecular weight of the eluted protein was determined
based on the elution volume and a standard calibration curve for the
column to give an estimate of the oligomeric state of the protein. SEC
fractions and in-process samples were analyzed by SDS–PAGE to
conﬁrm the success of puriﬁcation and determine which SEC frac-
tions to pool for ﬁnal concentration. After pooling the appropriate
SEC fractions, the protein was concentrated using an Amicon Ultra-
15 Centrifugal Filter Unit (Millipore, Carrigtwohill, Ireland) to 20–
30 mg ml
 1. 100–200 ml aliquots were then ﬂash-frozen in ﬂexible
eight-well strips (PCR strip tubes, Axygen, Union City, California,
USA) using liquid nitrogen and stored at 193 K.
2.3. Production of 6-His-MBP-3C protease
An engineered form of 3C protease was used for the removal of
non-native histidine tags from the N-terminus of recombinant target
proteins. This 6-His-MBP-3C protease construct was a generous gift
from Professor Eric Pﬁziky of the University of Rochester. It was
expressed following the same protocol as used for the large-scale
expression of SSGCID target proteins. 6-His-MBP-3C protease was
puriﬁed in three steps including primary IMAC, SEC and dialysis into
storage buffer. IMAC and SEC were performed just as they were for
other SSGCID proteins, with all of the buffers remaining the same
except for the lysis buffer, which did not contain the protease inhi-
bitor AEBSF (25 mM HEPES, 500 mM NaCl, 5% glycerol, 30 mM
imidazole, 0.025% sodium azide, 0.5% CHAPS, 10 mM MgCl2,1m M
TCEP, 0.05 mgm l
 1 lysozyme pH 7.0). Following SEC, peak fractions
were conﬁrmed by SDS–PAGE analysis, pooled and concentrated to
6–7 mg ml
 1. The concentrated sample was then dialyzed overnight
into storage buffer (25 mM HEPES, 200 mM NaCl, 1 mM TCEP, 50%
glycerol pH 7.5). During dialysis, the concentration of 6-His-MBP-3C
protease generally increased to 12–20 mg ml
 1 owing to the much
higher glycerol concentration in the storage buffer (50% glycerol)
versus the SEC buffer (5% glycerol) going into dialysis. The puriﬁed
6-His-MBP-3C protease was then stored at 253 K.
3. Results and discussion
An example of a typical puriﬁcation is that of the 24 kDa HAD-
superfamily hydrolase found in Ehrlichia chaffeensis (PDB entry
3kzx). The large-scale culture yielded medium expression levels with
medium solubility, as demonstrated by the total (T) and soluble
(S) lanes on the SDS–PAGE image (Fig. 2). The ﬁrst IMAC was
successful in removing most of the E. coli background proteins
[ﬂowthrough (FT) and pure (P) lanes on the left-hand side of the
SDS–PAGE] and 76 mg total protein was recovered. 3C protease
successfully cleaved all of the protein and a visible shift of about
2 kDa was seen on the gel. 68% of the protein (52 mg) was recovered
in the ﬂowthrough (FT; right-hand side of SDS–PAGE) and wash (W)
portions of the subtractive IMAC step, while the elution (E) portion
contained the rest of the cleaved target protein, the 3C protease and
DnaK, a metal-binding heat-shock protein native to E. coli (Baneyx
& Nannenga, 2010). SEC was run on the ﬂowthrough and wash
fractions and yielded a single symmetrical peak (fractions B4–C4
containing the peak are seen in Fig. 2). After pooling the appropriate
fractions (pooled fractions are marked in Fig. 2), the puriﬁed protein
was concentrated to 1.6 ml at 26.8 mg ml
 1 and stored at 193 K.
Including enzymatic cleavage and subtractive IMAC in our stan-
dard protocol not only removes the non-native His tag but also
laboratory communications
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Figure 2
A GelCode Blue-stained (Thermo Scientiﬁc, Rockford, Illinois, USA) SDS–PAGE
of samples from a typical puriﬁcation, represented in this case by recombinant
HAD-superfamily hydrolase from Ehrlichia chaffeensis. Lanes are labelled as
follows: M, molecular-weight standards; T, total protein; S, soluble fraction; FT,
ﬂowthrough (nonbound) from the ﬁrst IMAC column; P, puriﬁed protein after ﬁrst
IMAC column; B4–C4, successive size-exclusion chromatography (SEC) fractions
from peak (see Fig. 2), the dotted fractions were pooled for ﬁnal concentration;
3C+P, protein after overnight cleavage with 3C protease; FT, unbound protein from
second IMAC column after dialysis with 3C protease; W, protein from second
IMAC column that eluted in the wash fractions; E, protein eluted from the second
IMAC column with 500 mM imidazole. The identity of the DnaK protein band was
determined by gel extraction, trypsin digest and mass-spectrometric analysis.generally improves the purity ofthe protein. 3C protease was used for
enzymatic cleavage as it is active at 277 K in a wide range of buffers
(Tris, imidazole, PBS) including salt concentrations of 0.1–0.5 M with
a pH range of 6.8–8.2 (Walker et al., 1994). While no data have been
collected showing that maltose-binding protein (MBP) increases the
expression or solubility of 3C protease, MBP-fusion data have been
published for TEV protease, another protease that is very commonly
used by structural genomic centers. In one case, the use of an MBP
fusion, together with other factors such as the use of an autoinduction
method and modiﬁed expression plasmid genotypes, improved the
expression of soluble TEV protease to 400 mg per litre of cell culture
(Blommel & Fox, 2007). An improvement in the solubility of an
MBP-TEV protease fusion over histidine-tagged TEV protease has
also been presented by Kapust & Waugh (1999). Our MBP-fused
construct yielded highly soluble 6-His-MBP-3C protease with an
average yield of 52 mg (enough to carry out cleavage digestions for
2.6 g recombinant protein) from a 2 l expression volume of bacterial
cell culture. Furthermore, this enzyme was stable for at least six
months when stored in buffer containing 50% glycerol at 253 K.
Data analysis of enzymatic cleavage reactions and subtractive
IMAC reveals the high efﬁciency of 6-His-MBP-3C protease. Of 208
digestions with 3C protease, including proteins that passed puriﬁca-
tion and for which concentrations for each fraction in subtractive
IMAC were measured, 195 (94%) yielded complete cleavage. Partial
cleavage was seen for only 13 of the 208 total digestions performed
(6%). However, it should be noted that this was not a consequence of
inactive 6-His-MBP-3C protease, as parallel cleavages with different
recombinant proteins always cleaved to completion. In each incom-
plete cleavage the protein was observed to be a multimer based on its
apparent molecular weight during SEC. Thus, we hypothesize that 3C
cleavage may be incomplete owing to a lack of accessibility of the
3C cleavage site because of oligomeric protein–protein interactions.
Another group noted incomplete cleavage of oligomeric proteins
and hypothesized that the cleavage tags were not accessible in the
oligomers (Kenig et al., 2006). Of those 195 complete 3C digestions,
subtractive IMAC was successful 166 times (85%). A successful
IMAC recovers most of the protein in the ﬂowthrough and wash
fractions, leaving any contaminants bound to the Ni resin to be
removed in the elution fraction. This is analyzed quantitatively by
calculating the recovery, or the percentage of total protein (protein
obtained after the primary IMAC step in protein puriﬁcation)
recovered after subtractive IMAC, in the ﬂowthrough and wash
fractions. The median recovery of input protein in successful sub-
tractive IMAC was 80.2%. Non-ideal behavior was seen in 15% of
the subtractive IMAC outcomes, in which substantial quantities of
cleaved proteins were retained on the second IMAC column and
appeared in the elution fraction. If the elution fraction is pooled for
further processing, contaminants are reintroduced into the protein
sample, including the 3C protease, the His-tag peptide and native
IMAC-binding E. coli proteins. Depending on the size of the target
protein, these impurities may not be separated from the target
protein during SEC. Therefore, in almost all cases the elution fraction
was not pooled with the ﬂowthrough and wash fractions, and the
nonspeciﬁc binding of the recombinant protein resulted in lower
recovery. Tagless protein may bind to the Ni resin for a variety of
reasons, including the presence of surface clusters of histidine resi-
dues, metal-binding domains and/or hydrophobic patches that bind to
the Sepharose matrix (Bolanos-Garcia & Davies, 2006). Fortunately,
this non-ideal behaviour was observed for only 29 of 195 (15%)
successful 3C digestions, lowering the median percentage yield
recovered in these 29 instances to 55%. Thus, 3C protease and
subtractive IMAC have proven to be reliable for the cleavage and
increased purity of polyhistidine-tagged proteins.
3C cleavage followed by subtractive IMAC improved the like-
lihood that a recombinant protein will lead to an X-ray crystallo-
graphic structure (Fig. 3). For this analysis, we included all proteins
submitted to the crystallography group that have had sufﬁcient time
to undergo crystal trials and yield a structure. 276 proteins that have
been cleaved and undergone subtractive IMAC led to 44 structures
being made available to the scientiﬁc community through the Protein
Data Bank, a success rate of 15.9%. Alternatively, a total of 246
crystal trials on uncleaved proteins led to 32 structures, a success rate
of 13.0%. While this is an increase of only 2.9% in the number of
structures solved by the addition of cleavage and subtractive IMAC
steps, this seemingly small change represents a signiﬁcant improve-
ment over the ﬁve years of the project. During these ﬁve years, the
UW-PPG is projected to purify 2000 proteins. If we produce un-
cleaved proteins we project a yield of 260 solved structures, but if we
cleave and use subtractive IMAC we project a yield of 318 solved
structures. Better purity and removal of the histidine tag, which is
often disordered, are the most likely contributing factors to the
increase of the structure success rate. Owing to this signiﬁcant
increase in success rate, all SSGCID protein puriﬁcations performed
by UW-PPG include a cleavage step.
Of the structural genomics centers that choose to perform clea-
vage, 3C protease and TEV protease are most commonly used owing
to their high speciﬁcity and catalysis of cleavage to completion.
Catalytic efﬁciency is described by the kinetic parameter kcat/Km from
Lineweaver–Burk regression analysis, with a higher value indicating
a more complete reaction. The literature has shown higher efﬁciency
for 3C protease based on cleavage experiments carried out at 303 K.
However, it should be noted that this value is substrate-dependent.
Wang et al. (1997) showed that puriﬁed 3C protease had a kcat/Km
value of 840 M
 1 s
 1 for the substrate EALFQ-pNA. Alternatively,
kinetics studies by Miladi et al. (2011) showed a much lower kcat/Km
(260 M
 1 s
 1) for TEV protease. 6-His-TEV protease also had a
similar kcat/Km value of 270 M
 1 s
 1 for a different substrate and it
cleaved only 70% of the fusion protein in an overnight incubation at
303 K when mixed in a 1:14 enzyme:substrate ratio (Fang et al., 2007).
Our ratio of 1:50 enzyme:substrate led to complete cleavage 94% of
the time (see below). Therefore, based on the incomplete cleavage by
TEV protease and the lower kcat/Km values, 3C protease may be the
better option for enzymatic cleavage of recombinant tagged proteins.
The following success rates further attest to the validity and efﬁ-
ciency of the protein-puriﬁcation protocol with 3C cleavage devel-
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Figure 3
Structure success rate for uncleaved versus cleaved proteins. An increase of 2.9% is
seen in the structure success rate of cleaved proteins over uncleaved proteins. This
is likely to be a consequence of the removal of contaminating Ni-binding E. coli
proteins.oped by UW-PPG. Of 315 puriﬁcation attempts using the outlined
protocol, 39 were counted as failed puriﬁcations, giving an overall
success rate of 87.6%. The average amount of protein delivered for
crystallization trials was 53.0 mg and the median preparation was
38.7 mg. This quantity of protein allowed multiple crystal trials and
even cocrystallization with multiple ligands in certain cases. Following
puriﬁcation, crystallization trials were set up for each protein
according to a rational crystallization approach (Newman et al., 2005)
using the JCSG+ and PACT sparse-matrix screens from Emerald
BioSystems (Bainbridge Island, Washington, USA). 0.4 ml protein
solution was set up at 289 K with an equal volume of precipitant
against an 80 ml reservoir in sitting-drop vapor-diffusion format in
96-well Compact Jr plates (Emerald BioSystems, Bainbridge Island,
Washington, USA). These trials have been completed for 276 cleaved
proteins and resulted in the determination of 44 structures, a success
rate of 15.9%.
The high success rate further attests that the subtractive IMAC
puriﬁcation method described in this article is highly efﬁcient.
However, ongoing process improvements are required for this and
other procedures within the SSGCID structure-determination pipe-
line in order to continuously improve the output and cost-effective-
ness of structural genomics. Going forward, UW-PPG plans to focus
more attention on target selection prior to puriﬁcation. Rather than
simply picking targets that have passed expression testing, those that
show high expression and solubility of the protein product will be
prioritized, as these high expressors are 40% more likely to yield a
structure than low- or medium-expressing proteins (Choi et al., 2011).
Proteins which have greater expression and solubility going into
puriﬁcation generally have greater purity and yields, which undoub-
tably contributes to higher structure yields. Also, high solubility in
screening means that the protein is not likely to be misfolded and is
less likely toaggregate while itis beingprocessed. Therefore, all other
considerations being equal, targets with the best expression and
solubility proﬁles during screening will be moved to higher priority
for further processing.
Unfortunately, some proteins have low solubility and are prone to
becoming insoluble during the puriﬁcation procedure. If aggregation
is observed at any point during a puriﬁcation, a quick search of
PubMed or the Protein Data Bank (PDB) often reveals possible
ligands, such as metals, cofactors or substrates, which are added to the
proteins. These additives then bind to and theoretically stabilize the
protein so that it may continue to be processed. The Structural
Genomics Consortium used this approach together with differential
scanning ﬂuorimetry (DSF) and differential static light scattering
(DSLS) to optimize buffer conditions and screen both generic
libraries and focused libraries of ligands, detergents, metals, inhibitors
and other additives (Vedadi et al., 2006). They were able to increase
the thermostability of >50% of the 221 proteins tested by varying pH
and/or salt concentrations alone. In a more speciﬁc example, 84% of
32 kinases that were screened against a library of 500 kinase inhibi-
tors resulted in an increase in thermostability of >4 K upon addition
of the identiﬁed compound. These statistics provide strong evidence
that buffer optimization and ligand addition are legitimate methods
for rescuing aggregating proteins. By prioritizing targets with high
expression and attempting to stabilize problem proteins, it is the goal
of UW-PPG to increase success rates in crystallization trials and to
increase the number of structures being deposited in the PDB.
The results presented in this paper demonstrate that the SSGCID
protein-production group at the University of Washington has
successfully implemented a robust protein-production pipeline that
has supported the discovery of over 75 new protein structures a year
over the last three years. These structures can be accessed by the
scientiﬁc community through the PDB and are used in a wide range
of other projects, for example structure-based drug design. It is our
hope that our efforts may contribute to the expanding knowledge of
protein structure and the discovery of new medicines against signif-
icant pathogens.
The authors would like to thank the entire SSGCID team, espe-
cially the members of UW-PPG. The authors are grateful for the gifts
of the AVA0421 vector and the 3C protease expression vector from
Drs Elizabeth Grayhack and Eric Pﬁzicky at the University of
Rochester. Support for this research was funded by the National
Institute of Allergy and Infectious Diseases, the National Institutes of
Health and the Department of Health and Human Services under
Federal Contract No. HHSN272200700057C.
References
Alexandrov, A., Vignali, M., LaCount, D. J., Quartley, E., de Vries, C., De
Rosa, D., Babulski,J., Mitchell,S. F., Schoenfeld, L.W., Fields, S., Hol, W. G.,
Dumont, M. E., Phizicky, E. M. & Grayhack, E. J. (2004). Mol. Cell.
Proteomics, 3, 934–938.
Aslanidis, C. & de Jong, P. J. (1990). Nucleic Acids Res. 18, 6069–6074.
Baneyx, F. & Nannenga, B. L. (2010). Nature Chem. Biol. 6, 880–881.
Blommel, P. G. & Fox, B. G. (2007). Protein Expr. Purif. 55, 53–68.
Bolanos-Garcia, V. M. & Davies, O. R. (2006). Biochim. Biophys. Acta, 1760,
1304–1313.
Choi, R., Kelley, A., Leibly, D., Nakazawa Hewitt, S., Napuli, A. & Van
Voorhis, W. (2011). Acta Cryst. F67, 998–1005.
Fang, L., Jia, K.-Z., Tang, Y.-L., Ma, D.-Y., Yu, M. & Hua, Z.-C. (2007). Protein
Expr. Purif. 51, 102–109.
Hedhammar, M., Jung, H. R. & Hober, S. (2006). Protein Expr. Purif. 47,
422–426.
Kapust, R. B. & Waugh, D. S. (1999). Protein Sci. 8, 1668–1674.
Kenig, M., Peternel, S ˇ., Gaberc-Porekar, V. & Menart, V. (2006). J.
Chromatogr. A, 1101, 293–306.
Miladi, B., Bouallagui, H., Dridi, C., El Marjou, A., Boeuf, G., Di Martino, P.,
Dufour, F. & Elm’Selmi, A. (2011). Protein Expr. Purif. 75, 75–82.
Newman, J., Egan, D., Walter, T. S., Meged, R., Berry, I., Ben Jelloul, M.,
Sussman, J. L., Stuart, D. I. & Perrakis, A. (2005). Acta Cryst. D61, 1426–
1431.
Quartley, E., Alexandrov, A., Mikucki, M., Buckner, F. S., Hol, W. G., DeTitta,
G. T., Phizicky, E. M. & Grayhack, E. J. (2009). J. Struct. Funct. Genomics,
10, 233–247.
Studier, F. W. (2005). Protein Expr. Purif. 41, 207–234.
Vedadi, M. et al. (2006). Proc. Natl Acad. Sci. USA, 103, 15835–15840.
Walker, P. A., Leong, L. E., Ng, P. W., Tan, S. H., Waller, S., Murphy, D. &
Porter, A. G. (1994). Biotechnology, 12, 601–605.
Wang, Q. M., Johnson, R. B., Cox, G. A., Villarreal, E. C. & Loncharich, R. J.
(1997). Anal. Biochem. 252, 238–245.
laboratory communications
1014 Bryan et al.   High-throughput protein production and purification Acta Cryst. (2011). F67, 1010–1014